|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Unrealized (gain) loss on remeasurement of foreign currency | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Amortization of deferred contract costs | |||||
| Change in fair value of contingent consideration | |||||
| Deferred tax (benefit) provision | |||||
| Change in provision for uncollectible accounts | |||||
| Non-cash interest income | |||||
| Non-cash interest expense | |||||
| Amortization of debt issuance costs | |||||
| Net accretion of discounts and amortization of premiums on investments | |||||
| Changes in operating assets and liabilities, net of acquisition: | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Funds receivable from payment partners | |||||
| Prepaid expenses, other current assets and other assets | |||||
| Funds payable to clients | |||||
| Accounts payable, accrued expenses and other current liabilities | |||||
| Contingent consideration | |||||
| Other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Asset acquisition, net of cash acquired | |||||
| Contingent consideration paid for acquisitions | |||||
| Purchase of short-term and long-term investments | |||||
| Proceeds from the maturity and sale of short-term and long-term investments | |||||
| Capitalization of internally developed software | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from initial public offering, net of underwriting discounts and commissions | |||||
| Payment of costs related to initial public offering | |||||
| Proceeds from issuance of revolving credit facility | |||||
| Payment of revolving credit facility | |||||
| Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from issuance of common stock under public offering, net of underwriting discount and commissions | |||||
| Payments of costs related to public offering | |||||
| Payment of debt issuance costs | |||||
| Contingent consideration paid for acquisitions | |||||
| Payments of tax withholdings for net settled equity awards | |||||
| Common stock repurchased | |||||
| Proceeds from the issuance of stock under Employee Stock Purchase Plan | |||||
| Proceeds from exercise of stock options | |||||
| Deferred acquisition payment | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rates changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and Cash Equivalents | |||||
| Restricted Cash | |||||
| Total cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Cash and Cash Equivalents | |||||
| Restricted Cash | |||||
| Total cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow and noncash information | |||||
| Purchase of property and equipment in accounts payable | |||||
| Accrued excise tax related to common stock repurchase | |||||
| Capitalized stock-based compensation expense | |||||
| Cash paid for interest | |||||
| Issuance of common stock for acquisition | |||||
| Accretion of redeemable convertible preferred stock | |||||
| Issuance of common stock for retention bonus, Value | |||||
Loading...